Title : Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2‑mediated glycolysis.

Pub. Date : 2015 Mar

PMID : 25591943






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EGCG dose-dependently inhibited anchorage-independent growth and short-term EGCG exposure substantially decreased EGF-induced EGF receptor (EGFR), Akt and ERK1/2 activation, as well as the downregulation of hexokinase 2 (HK2). epigallocatechin gallate epidermal growth factor receptor Homo sapiens
2 EGCG dose-dependently inhibited anchorage-independent growth and short-term EGCG exposure substantially decreased EGF-induced EGF receptor (EGFR), Akt and ERK1/2 activation, as well as the downregulation of hexokinase 2 (HK2). epigallocatechin gallate epidermal growth factor receptor Homo sapiens
3 EGCG dose-dependently inhibited anchorage-independent growth and short-term EGCG exposure substantially decreased EGF-induced EGF receptor (EGFR), Akt and ERK1/2 activation, as well as the downregulation of hexokinase 2 (HK2). epigallocatechin gallate epidermal growth factor receptor Homo sapiens
4 EGCG dose-dependently inhibited anchorage-independent growth and short-term EGCG exposure substantially decreased EGF-induced EGF receptor (EGFR), Akt and ERK1/2 activation, as well as the downregulation of hexokinase 2 (HK2). epigallocatechin gallate epidermal growth factor receptor Homo sapiens